Area of research
Cancer Research · Molecular Biology
Research interest
Research focused on Osteosarcoma and Cancer research, with related work in Glycolysis, ROCK2, Ubiquitin. Notable publications include 'Ubiquitin-like protein FAT10 promotes osteosarcoma growth by modifying the ubiquitination and degradation of YAP1', 'ROCK2 promotes osteosarcoma growth and metastasis by modifying PFKFB3 ubiquitination and degradation', and '<p>Expression Profile of GINS Complex Predicts the Prognosis of Pancreatic Cancer Patients</p>'.
Reversal of <scp>MPPa</scp> ‐ <scp>PDT</scp> Resistance in Osteosarcoma by Targeting <scp>ROCK2</scp> ‐Mediated Autophagy
<scp>USP22</scp> Promotes Osteosarcoma Progression by Stabilising β‐Catenin and Upregulating <scp>HK2</scp> and Glycolysis
ROCK2 Promotes Osteosarcoma Growth and Glycolysis by Up-Regulating HKII via Phospho-PI3K/AKT Signalling
Circular RNA circANAPC2 mediates the impairment of endochondral ossification by miR‐874‐3p/SMAD3 signalling pathway in idiopathic short stature
<p>Expression Profile of GINS Complex Predicts the Prognosis of Pancreatic Cancer Patients</p>
Ubiquitin-like protein FAT10 promotes osteosarcoma glycolysis and growth by upregulating PFKFB3 via stabilization of EGFR.
PubMed 2020cited by 24position: middle
ROCK2 mediates osteosarcoma progression and TRAIL resistance by modulating O-GlcNAc transferase degradation.
PubMed 2020cited by 22position: middle
Ubiquitin-like protein FAT10 promotes osteosarcoma growth by modifying the ubiquitination and degradation of YAP1
ROCK2 promotes osteosarcoma growth and metastasis by modifying PFKFB3 ubiquitination and degradation